Title of article :
68Ga–Prostate-Specific Membrane Antigen, A Potential Radiopharmaceutical in PET/CT To detect primary Cholangiocarcinoma
Author/Authors :
Chahinian ، Rita Department of Clinical Diagnostic Radiology - American University of Beirut Medical Center , El-Amine ، Ahmad Department of Clinical Diagnostic Radiology - American University of Beirut Medical Center , Matar ، Sayed Department of Pathology and Laboratory Medicine - American University of Beirut Medical Center , Annan ، Mostafa Department of Clinical Diagnostic Radiology - American University of Beirut Medical Center , Shamseddine ، Ali Department of Internal Medicine, Hematology/Oncology Division - American University of Beirut Medical Center , Haidar ، Mohamad Department of Clinical Diagnostic Radiology - American University of Beirut Medical Center
Abstract :
68Ga Prostate-specific membrane antigen (PSMA) is an increasingly popular radiopharmaceutical tracer in prostate cancer and is becoming increasingly researched in other cancers such as breast cancer, renal cell carcinoma, glioblastoma multiforme, among others. Cholangiocarcinoma is the second most common primary hepatic malignant tumor; it is an aggressive tumor with a 5-year survival rate of less than 5 %. We herein report a case of primary cholangiocarcinoma detected on 68Ga-PSMA PET-CT conducted as part of follow up for prostate cancer and confirmed by biopsy and immunohistochemistry.
Keywords :
PSMA , PET , CT , Cholangiocarcinoma
Journal title :
Asia Oceania Journal of Nuclear Medicine and Biology
Journal title :
Asia Oceania Journal of Nuclear Medicine and Biology
